MENU
+Compare
IHE
ETF ticker: NYSE ARCA
AS OF
Jun 4 closing price
Price
$65.62
Change
+$0.15 (+0.23%)
Net Assets
559.62M

IHE stock forecast, quote, news & analysis

The investment seeks to track the investment results of the Dow Jones U... Show more

Category: #Health
IHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IHE with price predictions
Jun 04, 2025

IHE in upward trend: price rose above 50-day moving average on June 02, 2025

IHE moved above its 50-day moving average on June 02, 2025 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 28, 2025. You may want to consider a long position or call options on IHE as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IHE just turned positive on May 27, 2025. Looking at past instances where IHE's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IHE advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .

IHE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IHE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares US Pharmaceuticals ETF ETF is 47.31B. The market cap for tickers in the group ranges from 195.7M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is OMER at 195.7M.

High and low price notable news

The average weekly price growth across all stocks in the iShares US Pharmaceuticals ETF ETF was 3%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was -4%. ELVN experienced the highest price growth at 39%, while CORT experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the iShares US Pharmaceuticals ETF ETF was 14%. For the same stocks of the ETF, the average monthly volume growth was -14% and the average quarterly volume growth was 23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 73
Price Growth Rating: 58
SMR Rating: 71
Profit Risk Rating: 77
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
IHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com